Calyxt, Inc. (CLXT) Receives $29.05 Consensus Price Target from Brokerages

Calyxt, Inc. (NASDAQ:CLXT) has been assigned an average recommendation of “Buy” from the six ratings firms that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $29.05.

Several equities analysts have commented on the company. Zacks Investment Research raised Calyxt from a “sell” rating to a “hold” rating in a report on Tuesday, November 28th. BMO Capital Markets assumed coverage on Calyxt in a report on Monday, October 30th. They issued an “outperform” rating and a $32.00 price target for the company. Jefferies Group upped their price target on Calyxt to $27.00 and gave the company a “buy” rating in a report on Wednesday, November 1st. Ladenburg Thalmann Financial Services assumed coverage on Calyxt in a report on Wednesday, December 20th. They issued a “buy” rating and a $34.25 price target for the company. Finally, Citigroup cut their price target on Calyxt from $27.00 to $22.00 and set a “neutral” rating for the company in a report on Thursday, November 16th.

Several institutional investors and hedge funds have recently modified their holdings of CLXT. American International Group Inc. acquired a new position in shares of Calyxt in the 3rd quarter worth approximately $133,000. California State Teachers Retirement System acquired a new position in shares of Calyxt in the 3rd quarter worth approximately $323,000. Schwab Charles Investment Management Inc. acquired a new position in shares of Calyxt in the 3rd quarter worth approximately $358,000. Bank of New York Mellon Corp acquired a new position in shares of Calyxt in the 3rd quarter worth approximately $542,000. Finally, Wells Fargo & Company MN raised its holdings in shares of Calyxt by 1,421.9% in the 4th quarter. Wells Fargo & Company MN now owns 30,788 shares of the company’s stock worth $678,000 after buying an additional 28,765 shares in the last quarter. 21.13% of the stock is owned by institutional investors and hedge funds.

Calyxt (NASDAQ CLXT) traded down $0.18 during trading on Thursday, reaching $21.32. The company’s stock had a trading volume of 51,167 shares, compared to its average volume of 50,103. The company has a quick ratio of 12.41, a current ratio of 12.41 and a debt-to-equity ratio of 0.13. Calyxt has a 12-month low of $9.26 and a 12-month high of $31.89.

Calyxt (NASDAQ:CLXT) last posted its quarterly earnings results on Monday, November 13th. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.35). Calyxt had a negative net margin of 5,969.52% and a negative return on equity of 101.69%. analysts expect that Calyxt will post -1.07 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Calyxt, Inc. (CLXT) Receives $29.05 Consensus Price Target from Brokerages” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://stocknewstimes.com/2018/02/11/calyxt-inc-clxt-receives-29-05-consensus-price-target-from-brokerages.html.

Calyxt Company Profile

Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.

Analyst Recommendations for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply